rs10495453
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000447095.5(FMN2):c.-133+13200G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0956 in 152,014 control chromosomes in the GnomAD database, including 1,307 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.096 ( 1307 hom., cov: 33)
Consequence
FMN2
ENST00000447095.5 intron
ENST00000447095.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.23
Publications
2 publications found
Genes affected
FMN2 (HGNC:14074): (formin 2) This gene is a member of the formin homology protein family. The encoded protein is thought to have essential roles in organization of the actin cytoskeleton and in cell polarity. This protein mediates the formation of an actin mesh that positions the spindle during oogenesis and also regulates the formation of actin filaments in the nucleus. This protein also forms a perinuclear actin/focal-adhesion system that regulates the shape and position of the nucleus during cell migration. Mutations in this gene have been associated with infertility and also with an autosomal recessive form of intellectual disability (MRT47). Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jul 2017]
FMN2 Gene-Disease associations (from GenCC):
- intellectual disability, autosomal recessive 47Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- autosomal recessive non-syndromic intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.225 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0956 AC: 14516AN: 151896Hom.: 1304 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
14516
AN:
151896
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0956 AC: 14536AN: 152014Hom.: 1307 Cov.: 33 AF XY: 0.0945 AC XY: 7022AN XY: 74312 show subpopulations
GnomAD4 genome
AF:
AC:
14536
AN:
152014
Hom.:
Cov.:
33
AF XY:
AC XY:
7022
AN XY:
74312
show subpopulations
African (AFR)
AF:
AC:
9480
AN:
41418
American (AMR)
AF:
AC:
774
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
202
AN:
3466
East Asian (EAS)
AF:
AC:
626
AN:
5164
South Asian (SAS)
AF:
AC:
429
AN:
4812
European-Finnish (FIN)
AF:
AC:
226
AN:
10582
Middle Eastern (MID)
AF:
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2598
AN:
67978
Other (OTH)
AF:
AC:
160
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
597
1193
1790
2386
2983
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
373
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.